Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|
Ticker | Company | Price | Change | Chg % | Mkt Cap | |
---|---|---|---|---|---|---|
GTBP | GT Biopharma | 10.44 | 0.00 | 0% | 223.1M |
You can purchase shares of GT Biopharma (NASDAQ: GTBP) through any online brokerage.
Other companies in GT Biopharma’s space includes: Voyager Therapeutics (NASDAQ:VYGR), DiaMedica Therapeutics (NASDAQ:DMAC) and Calithera Biosciences (NASDAQ:CALA).
The latest price target for GT Biopharma (NASDAQ: GTBP) was reported by Roth Capital on 2021-03-17. The analyst firm set a price target for 25.00 expecting GTBP to rise to within 12 months (a possible 139.46% upside). 1 analyst firms have reported ratings in the last year.
The stock price for GT Biopharma (NASDAQ: GTBP) is $10.44 last updated Fri Apr 09 2021 20:00:02 GMT+0000 (Coordinated Universal Time).
There are no upcoming dividends for GT Biopharma.
There are no earnings for GT Biopharma
There is no upcoming split for GT Biopharma.